المؤلفون: Erfani S; Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran., Moghimi A; Rayan Center for Neuroscience and Behavior, Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran., Aboutaleb N; Physiology Research Center, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran. dr.nabotaleb@gmail.com.; Department of Physiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran. dr.nabotaleb@gmail.com., Khaksari M; Addiction Research Center, Shahroud University of Medical Sciences, Shahroud, Iran.

المصدر: Metabolic brain disease [Metab Brain Dis] 2019 Feb; Vol. 34 (1), pp. 79-85. Date of Electronic Publication: 2018 Sep 30.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 8610370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7365 (Electronic) Linking ISSN: 08857490 NLM ISO Abbreviation: Metab Brain Dis Subsets: MEDLINE

مواضيع طبية MeSH: Antioxidants/*therapeutic use , Calcium-Binding Proteins/*therapeutic use , Cell Death/*drug effects , DNA-Binding Proteins/*therapeutic use , Hippocampus/*drug effects , Nerve Tissue Proteins/*therapeutic use , Neurons/*drug effects , Neuroprotective Agents/*therapeutic use , Reperfusion Injury/*prevention & control, Animals ; Antioxidants/pharmacology ; Apoptosis/drug effects ; Calcium-Binding Proteins/pharmacology ; Caspase 3/metabolism ; DNA-Binding Proteins/pharmacology ; Disease Models, Animal ; Hippocampus/metabolism ; Male ; Malondialdehyde/metabolism ; Nerve Tissue Proteins/pharmacology ; Neurons/metabolism ; Neuroprotective Agents/pharmacology ; Nucleobindins ; Oxidative Stress/drug effects ; Rats ; Rats, Wistar ; Superoxide Dismutase/metabolism